Surrey Heartlands

Joint Formulary & PAD

Pirfenidone - Idiopathic pulmonary fibrosis

You are here : Home > Formulary Search > Pirfenidone - Idiopathic pulmonary fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
NICE
Restrictions / Comments :
Documents :
 
Webpage
NICE TA504 - Pirfenidone for treating idiopathic pulmonary fibrosis - Feb 2018

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pirfenidone
Indication :
Idiopathic pulmonary fibrosis
Group Name :
Keywords :
NICE
Brand Names Include :
Esbriet
Important Information :
NHSE Specialist Commissioned Services only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Pirfenidone is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Idiopathic pulmonary fibrosis.

Committee Recommendations (1)

28 Feb 24 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.